4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-018782
Chief Business Officer sold 44,000 shares at an average $21.78 ($958,220)
- Chief Business Officer acquired 44,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martin Michael Robert Chief Business Officer | 2021-09-14 | Option exercise | +44,000 | $5.30 | $233,200 | 220,861 | D: show line 1 in the form |
| Martin Michael Robert Chief Business Officer | 2021-09-14 | Sale | −14,000 | $21.73 | $304,220 | 206,861 | D: show line 2 in the form |
| Martin Michael Robert Chief Business Officer | 2021-09-14 | Sale | −30,000 | $21.80 | $654,000 | 176,861 | D: show line 3 in the form |
| Open-market sales · 44,000 sh · avg $21.78 · $958,220 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Martin Michael Robert Chief Business Officer | 2021-09-14 | Option exercise · Option Grant (right to buy) | −44,000 | 36,000 | D: show line 4 in the form |
Loading xslF345X03/wf-form4_163182609831779.xml…